These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
228 related items for PubMed ID: 26923083
1. Comparison of the immunogenicity and safety of pentavalent vaccine Quinvaxem in a compact prefilled auto-disabled (cPAD) injection system versus single-dose vials in healthy infants: a phase 3, open-label, randomized, parallel-group, non-inferiority study. Capeding MR, Alberto E, Versteilen A, Rauscher M, Bagchi P, Palacios PI. Int J Infect Dis; 2016 May; 46():71-8. PubMed ID: 26923083 [Abstract] [Full Text] [Related]
4. Reactogenicity and immunogenicity profiles of a novel pentavalent diphtheria-tetanus-whole cell pertussis-hepatitis B and Haemophilus influenzae type B vaccine: a randomized dose-ranging trial of the Hib tetanus-conjugate content. Hla KH, Thein SA, Aye A, Han HH, Bock HL, David MP, Schuerman L. Pediatr Infect Dis J; 2006 Aug; 25(8):706-12. PubMed ID: 16874170 [Abstract] [Full Text] [Related]
5. Combined DTP-HBV-HIB vaccine versus separately administered DTP-HBV and HIB vaccines for primary prevention of diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae B (HIB). Bar-On ES, Goldberg E, Hellmann S, Leibovici L. Cochrane Database Syst Rev; 2012 Apr 18; 2012(4):CD005530. PubMed ID: 22513932 [Abstract] [Full Text] [Related]
6. Primary and booster immunization with a diphtheria, tetanus, acellular pertussis, hepatitis B (DTPa-HBV) and Haemophilus influenzae type b (Hib) vaccine administered separately or together is safe and immunogenic. Marshall H, McIntyre P, Roberton D, Dinan L, Hardt K. Int J Infect Dis; 2010 Jan 18; 14(1):e41-9. PubMed ID: 19467896 [Abstract] [Full Text] [Related]
7. Immunogenicity and safety of a new hexavalent vaccine (DTaP5-IPV-HB-Hib) administered in a mixed primary series schedule with a pentavalent vaccine (DTaP5-IPV-Hib). Martinón-Torres F, Boisnard F, Thomas S, Sadorge C, Borrow R, PRI02C study group. Vaccine; 2017 Jun 27; 35(30):3764-3772. PubMed ID: 28583305 [Abstract] [Full Text] [Related]
8. Immunological persistence in 5 y olds previously vaccinated with hexavalent DTPa-HBV-IPV/Hib at 3, 5, and 11 months of age. Silfverdal SA, Assudani D, Kuriyakose S, Van Der Meeren O. Hum Vaccin Immunother; 2014 Jun 27; 10(10):2795-8. PubMed ID: 25483640 [Abstract] [Full Text] [Related]
9. The development of a new heptavalent diphtheria-tetanus-whole cell pertussis-hepatitis B-Haemophilus influenzae type b-Neisseria meningitidis serogroups A and C vaccine: a randomized dose-ranging trial of the conjugate vaccine components. Gatchalian S, Palestroque E, De Vleeschauwer I, Han HH, Poolman J, Schuerman L, Dobbelaere K, Boutriau D. Int J Infect Dis; 2008 May 27; 12(3):278-88. PubMed ID: 17981067 [Abstract] [Full Text] [Related]
10. Combined DTP-HBV-HIB vaccine versus separately administered DTP-HBV and HIB vaccines for primary prevention of diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae B (HIB). Bar-On ES, Goldberg E, Fraser A, Vidal L, Hellmann S, Leibovici L. Cochrane Database Syst Rev; 2009 Jul 08; (3):CD005530. PubMed ID: 19588375 [Abstract] [Full Text] [Related]
11. Interchangeability of Quinvaxem during primary vaccination schedules: results from a phase IV, single-blind, randomized, controlled, single-center, non-inferiority study. Capeding MR, Jica C, Macura-Biegun A, Rauscher M, Alberto E. Vaccine; 2014 Feb 07; 32(7):888-94. PubMed ID: 24176498 [Abstract] [Full Text] [Related]
12. Spotlight on DTPa-HBV-IPV/Hib Vaccine (Infanrix hexa). Dhillon S. BioDrugs; 2010 Oct 01; 24(5):299-302. PubMed ID: 20795752 [Abstract] [Full Text] [Related]
13. Immunogenicity and reactogenicity of a Haemophilus influenzae type b tetanus conjugate vaccine when administered separately or mixed with concomitant diphtheria-tetanus-toxoid and acellular pertussis vaccine for primary and for booster immunizations. Schmitt HJ, Zepp F, Müschenborn S, Sümenicht G, Schuind A, Beutel K, Knuf M, Bock HL, Bogaerts H, Clemens R. Eur J Pediatr; 1998 Mar 01; 157(3):208-14. PubMed ID: 9537487 [Abstract] [Full Text] [Related]
14. Effect of prophylactic or therapeutic administration of paracetamol on immune response to DTwP-HepB-Hib combination vaccine in Indian infants. Sil A, Ravi MD, Patnaik BN, Dhingra MS, Dupuy M, Gandhi DJ, Dhaded SM, Dubey AP, Kundu R, Lalwani SK, Chhatwal J, Mathew LG, Gupta M, Sharma SD, Bavdekar SB, Rout SP, Jayanth MV, D'Cor NA, Mangarule SA, Ravinuthala S, Reddy E J. Vaccine; 2017 May 19; 35(22):2999-3006. PubMed ID: 28449972 [Abstract] [Full Text] [Related]
15. Safety and immunogenicity of a toddler dose following an infant series of a hexavalent diphtheria, tetanus, acellular pertussis, inactivated poliovirus, Haemophilus influenzae type b, hepatitis B vaccine administered concurrently or at separate visits with a heptavalent pneumococcal conjugate vaccine. Halperin SA, Tapiéro B, Dionne M, Meekison W, Diaz-Mitoma F, Zickler P, Rubin E, Embree J, Bhuyan P, Lee A, Li M, Tomovici A. Pediatr Infect Dis J; 2014 Jan 19; 33(1):73-80. PubMed ID: 24346596 [Abstract] [Full Text] [Related]
16. A prospective, observational, multi-center, post-marketing safety surveillance study of the GSK combined vaccine against diphtheria, tetanus, pertussis, poliomyelitis, and Haemophilus influenzae type b invasive infections (DTaP-IPV/Hib) in South Korean infants. Elenge DM, Heo JS, Kim SS, Kim YK, Lee JH, Xavier S, Bahar E, Dos Santos G, Guignard A. Hum Vaccin Immunother; 2024 Dec 31; 20(1):2406060. PubMed ID: 39376187 [Abstract] [Full Text] [Related]
17. Immunogenicity and reactogenicity of primary immunization with a hexavalent diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio-Haemophilus influenzae type B vaccine coadministered with two doses of a meningococcal C-tetanus toxoid conjugate vaccine. Tejedor JC, Moro M, Ruiz-Contreras J, Castro J, Gómez-Campderá JA, Navarro ML, Merino JM, Martín-Ancel A, Roca J, García-del-Río M, Jurado A, Díez-Delgado FJ, Omeñaca F, García-Sicilia J, Boceta R, García-Corbeira P, Jacquet JM, Collard A, Schuerman L, Spanish DTaP-HBV-IPV-097 Study Group. Pediatr Infect Dis J; 2006 Aug 31; 25(8):713-20. PubMed ID: 16874171 [Abstract] [Full Text] [Related]
18. Safety, immune lot-to-lot consistency and non-inferiority of a fully liquid pentavalent DTwp-HepB-Hib vaccine in healthy Indian toddlers and infants. Gandhi DJ, Dhaded SM, Ravi MD, Dubey AP, Kundu R, Lalwani SK, Chhatwal J, Mathew LG, Gupta M, Sharma SD, Bavdekar SB, Jayanth MV, Ravinuthala S, Sil A, Dhingra MS. Hum Vaccin Immunother; 2016 Apr 02; 12(4):946-54. PubMed ID: 26580093 [Abstract] [Full Text] [Related]
19. Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine does not depress serologic responses to diphtheria, tetanus or pertussis antigens when coadministered in the same syringe with diphtheria-tetanus-pertussis vaccine at two, four and six months of age. Avendano A, Ferreccio C, Lagos R, Horwitz I, Cayazzo M, Fritzell B, Meschievitz C, Levine M. Pediatr Infect Dis J; 1993 Aug 02; 12(8):638-43. PubMed ID: 8414775 [Abstract] [Full Text] [Related]
20. Immunogenicity, reactogenicity and safety of three-dose primary and booster vaccination with combined diphtheria-tetanus-whole-cell pertussis-hepatitis B-reduced antigen content Haemophilus influenzae type b vaccine in Filipino children. Gatchalian SR, Ramakrishnan G, Bock HL, Lefevre I, Jacquet JM. Hum Vaccin; 2010 Aug 02; 6(8):664-72. PubMed ID: 20657177 [Abstract] [Full Text] [Related] Page: [Next] [New Search]